$HALB -- December 17, 2020 / Halberd Corp. (OTC PINK:HALB) announced they are pursuing development of their latest treatment variation in the fight against COVID-19. Halberd's provisional patent application, "Method For Treating And Curing Covid-19 Infection By Utilizing Radio Frequency Extracorporeally To Eradicate The Virus," was filed last month. The procedure is designed to treat infected blood which has been dosed with a specific antibody compound and then exposed to tuned radio frequencies in an extracorporeal manner.

#HALB